Top Markets
#1 Purr Purr +62.46%
#2 Pons Pons +55.25%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 TENDIES TENDIES +39.28%
#5 Non-Playable Coin Non-Playable Coin +34.62%
#6 Morpho Morpho +27.07%
#7 Cash Cat Cash Cat +26.52%
#8 Kinetiq Kinetiq +24.33%
#9 StonkBroker StonkBroker +23.38%
#10 Grass Grass +20.89%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Fangzhou Inc. Fangzhou Inc.

Fangzhou Inc.

6086
Clasificación en acciones #20933
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online... Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Precio por acción
$0.08571057
Última sincronización: 2026-08-21
Capitalización bursátil
$118.75M
Cambio (1 día)
0.00%
Cambio (1 año)
-82.69%
País
CN
Comercio Fangzhou Inc. (6086)

Categoría

Healthcare
Ganancias de Fangzhou Inc. (6086)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Fangzhou Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Fangzhou Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US